Polypeptide proteinase inhibitor from human articular cartilage

Area of Science:

• Biochemistry
• Molecular Biology
• Cartilage Research

Background:

• Human articular cartilage contains proteinase inhibitors crucial for joint health.
• Understanding these inhibitors is key to addressing cartilage degradation in diseases like osteoarthritis.

Purpose of the Study:

• To purify and characterize a novel proteinase inhibitor from human articular cartilage.
• To investigate the inhibitor's composition, enzymatic activity, and interactions within the cartilage matrix.

Main Methods:

• Purification using Sephadex G-75, heparin-Sepharose, and octyl-Sepharose affinity chromatography.
• Characterization via amino acid analysis, sedimentation equilibrium, and enzyme inhibition assays.
• Interaction studies using gel exclusion chromatography and polyacrylamide electrophoresis.

Main Results:

• A strongly cationic inhibitor, composed of two non-identical polypeptides (MW ~3500 each), was purified.
• The inhibitor targets serine proteinases, bacterial collagenase, and pepsin, but not thermolysin or cysteine proteinases.
• The inhibitor binds to heparin, keratan sulfate, proteoglycan subunits, and link proteins.

Conclusions:

• The human cartilage inhibitor is a unique, multi-functional protein.
• Its localization on proteoglycan complexes suggests a protective role against matrix degradation.
• This inhibitor may be a potential therapeutic target for cartilage-related disorders.